Palisade Bio, Inc.
(NASDAQ : CUR)

( )
CUR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.10%345.400.0%$4305.01m
BNTXBioNTech SE 1.75%297.500.0%$826.30m
NVAXNovavax, Inc. -1.10%133.5179.4%$750.47m
AMGNAmgen, Inc. 0.00%208.681.4%$526.19m
REGNRegeneron Pharmaceuticals, Inc. 0.00%592.152.7%$478.99m
SNSSSunesis Pharmaceuticals, Inc. 0.00%6.210.7%$434.10m
GILDGilead Sciences, Inc. -0.66%67.281.0%$395.23m
CCXIChemoCentryx, Inc. -0.83%33.442.9%$383.29m
ILMNIllumina, Inc. -0.02%417.093.3%$357.10m
XLRNAcceleron Pharma, Inc. 0.00%173.785.3%$335.39m
OCGNOcugen, Inc. 5.03%9.610.0%$318.59m
VRTXVertex Pharmaceuticals, Inc. 0.23%184.501.9%$274.69m
BIIBBiogen, Inc. 0.00%271.121.8%$271.81m
XENEXenon Pharmaceuticals, Inc. 0.00%30.570.4%$164.85m
CRSPCRISPR Therapeutics AG 0.05%95.110.6%$159.15m

Company Profile

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company is headquartered in Carlsbad, CA.